Targeting CD47 enhanced the antitumor immunity of PD-L1 blockade in B-cell lymphoma.
Nan Y, Zhang X, Wang S, Xu C, Wang Y, Han L, Luan J, Hu X, Chen W, Cao Z, Zhu Z, Zeng X, Fan J, Ye L, Shi X, Ju D.
Nan Y, et al. Among authors: han l.
Immunotherapy. 2023 Feb;15(3):175-187. doi: 10.2217/imt-2022-0087. Epub 2023 Feb 1.
Immunotherapy. 2023.
PMID: 36727256